Advanced gout – case study

Authors

  • Małgorzata Kądziela Oddział Reumatologii Szpital Wojewódzki nr 2 w Rzeszowie im. św. Jadwigi Królowej Polski
  • Iga Klonowska Oddział Reumatologii Szpital Wojewódzki nr 2 w Rzeszowie im. św. Jadwigi Królowej Polski

Keywords:

gout / gouty arthritis, tophi, treatment reducing levels of uric acid

Abstract

Gout is a disease caused by a deposit of monosodium urate crystals in the tissue. Joints are frequently affected, which is usually manifested by attacks of severe pain, swelling of the affected joint. The deposit of monosodium urate crystals is caused by the increased level of uric acid in the blood (hyperuricemia) above 6.5 mg / dl, which is the result of its excessive production or decreased excretion from the body. Gout occurs in 1-2% of the population, mostly middle-aged and elderly men (7% of men over 65 suffer from this condition). Women are diagnosed with gout less frequently, and the disease develops almost exclusively after menopause[1]. The incidence of gout clearly increases together with population ageing, lifestyle changes and eating habits. Excessive production of uric acid may be also caused by taking diuretics (especially thiazides) and acetylsalicylic acid in lower doses as well as high consumption of meat, seafood and alcohol (especially beer). This paper presents a case of 55-year-old man suffering from gout in chronic (advanced) stage with significant damage to the locomotor system. The first symptoms suggested a diagnosis of early stages of rheumatoid arthritis. Only after some time gout symptoms became more evident. The patient was treated with uric acid production blockers since the onset of the disease occurred. Even though he also used a low-purine diet and rehabilitation, a high level of uric acid in blood stream still maintained and joint destruction progressed. The only chance to improve the function of the locomotor system considering this patient it seems to be a surgical procedure removing the tophi around the joints or a new generation of drugs such as: febuxostat.

Downloads

Download data is not yet available.

References

Conway R. The real world of gout. The Journal of Rheumatology 2013; 6: 755-757

Gińdzieńska-Sieśkiewicz E., Sierakowski S,Domysłowska I , Sulik A. Dna moczanowa- aktualne spojrzenie na diagnostykę i leczenie. Reumatologia 2010; 6:425-428

Sivera F, Andrés M, Carmona L i wsp. Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative. Ann Rheum Dis 2014; 73:328–335

Dalbeth N, Fransen J, Jansen TL, Neogi T, Schumacher HR, Taylor WJ. New classification criteria for gout: a framework for progress. Rheumatology 2013; 10:1748-1753.

Majdan M. Zapalenie stawów wywołane przez kryształy. W: Puszczewicz M : Wielka interna. Reumatologia, Warszawa, Medical Tribune Polska, 2010, 317-324

Roddy E, Doherty M. Treatment of hyperuricaemia and gout. Clin Med 2013; 13:400-403

Wechalekar MD, Vinik O, Schlesinger N, Buchbinder R. Intra-articular glucocorticoids for acute gout. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009920.pub2/full (30.04.2013)

Goldfarb DS, Macdonald PA, Gunawardhana L, Chefo S, McLean L. Randomized Controlled Trial of Febuxostat Versus Allopurinol or Placebo in Individuals with Higher Urinary Uric Acid Excretion and Calcium Stones.Clin J Am Soc Nephrol. 2013; 11:1960-1967

Dalbeth N, House ME, Gamble GD i wsp.Population-specific influence of SLC2A9 genotype on the acute hyperuricaemic response to a fructose load.Ann Rheum Dis Ann Rheum Dis 2013; 11:1868-1873

Qing YF, Zhang QB, Zhou JG. Innate immunity functional gene polymorphisms and gout susceptibility. Gene 2013; 2:412–414

Meng DM, Zhou YJ, Wang L,i wsp. Polymorphisms in the NLRP3 gene and risk of primary gouty arthritis. Molecular Medicine Reports 2013; 6:1761-1766

Tran TH, Pham JT, Shafeeq H, Manigault KR, Arya V. Role of interleukin-1 inhibitors in the management of gout. Pharmacotherapy 2013; 7:744-753

Lee SS, Chen MC, Chou YH, Lin SD, Lai CS, Chen YC. Timing of intra-lesion shaving for surgical treatment of chronic tophus. Journal of Plastic, Reconstructive & Aesthetic Surgery 2013; 8:1131-1137

Published

2014-06-30

How to Cite

Kądziela, M., & Klonowska, I. (2014). Advanced gout – case study. European Journal of Clinical and Experimental Medicine, 12(2), 190–199. Retrieved from https://journals.ur.edu.pl/ejcem/article/view/12572